Health Economics Unit, University of Cape Town School of Public Health and Family Medicine, Cape Town, Western Cape, South Africa.
Alcohol and Drug Abuse Research Unit, South African Medical Research Council, Tygerburg, Western Cape, South Africa.
BMJ Open. 2019 May 14;9(5):e026973. doi: 10.1136/bmjopen-2018-026973.
Depression and alcohol use disorders are international public health priorities for which there is a substantial treatment gap. Brief mental health interventions delivered by lay health workers in primary care services may reduce this gap. There is limited economic evidence assessing the cost-effectiveness of such interventions in low-income and middle-income countries. This paper describes the proposed economic evaluation of a health systems intervention testing the effectiveness, cost-effectiveness and cost-utility of two task-sharing approaches to integrating services for common mental disorders with HIV and diabetes primary care services.
This evaluation will be conducted as part of a three-armed cluster randomised controlled trial of clinical effectiveness. Trial clinical outcome measures will include primary outcomes for risk of depression and alcohol use, and secondary outcomes for risk of chronic disease (HIV and diabetes) treatment failure. The cost-effectiveness analysis will evaluate cost per unit change in Alcohol Use Disorder Identification Test and Centre for Epidemiological Studies scale on Depression scores as well as cost per unit change in HIV RNA viral load and haemoglobin A1c, producing results of provider and patient cost per patient year for each study arm and chronic disease. The cost utility analyses will provide results of cost per quality-adjusted life year gained. Additional analyses relevant for implementation including budget impact analyses will be conducted to inform the development of a business case for scaling up the country's investment in mental health services.
The Western Cape Department of Health (WCDoH) (WC2016_RP6_9), the South African Medical Research Council (EC 004-2/2015), the University of Cape Town (089/2015) and Oxford University (OxTREC 2-17) provided ethical approval for this study. Results dissemination will include policy briefs, social media, peer-reviewed papers, a policy dialogue workshop and press briefings.
PACTR201610001825405.
抑郁和酒精使用障碍是国际公共卫生的重点关注领域,在这些领域存在着大量的治疗缺口。在初级保健服务中,由非专业卫生工作者提供的简短心理健康干预措施可能会缩小这一差距。在中低收入国家,评估这些干预措施的成本效益的经济证据有限。本文描述了对一项卫生系统干预措施的经济评估,该干预措施测试了两种任务分担方法的有效性、成本效益和成本效用,这两种方法用于将常见精神障碍服务与艾滋病毒和糖尿病初级保健服务相结合。
这项评估将作为一项三臂集群随机对照试验的一部分进行,该试验评估了临床效果。试验的临床结果测量将包括抑郁和酒精使用风险的主要结果,以及慢性疾病(艾滋病毒和糖尿病)治疗失败的次要结果。成本效益分析将评估酒精使用障碍识别测试和流行病学研究中心抑郁量表评分每单位变化的成本,以及艾滋病毒 RNA 病毒载量和血红蛋白 A1c 每单位变化的成本,为每个研究臂和慢性疾病提供每个患者每年的提供者和患者成本。成本效用分析将提供每获得一个质量调整生命年的成本。将进行与实施相关的额外分析,包括预算影响分析,为扩大国家对精神卫生服务的投资提供商业案例。
西开普省卫生部(WCDoH)(WC2016_RP6_9)、南非医学研究理事会(EC 004-2/2015)、开普敦大学(089/2015)和牛津大学(OxTREC 2-17)为这项研究提供了伦理批准。结果传播将包括政策简报、社交媒体、同行评议论文、政策对话研讨会和新闻发布会。
PACTR201610001825405。